JPRN-UMIN000025835
Recruiting
未知
Analysis of the responsible genome by the next generation sequencing (NGS) for drug sensitivity and prediction of prognosis in patients with newly diagnosed untreated multiple myeloma - Gene analysis using NGS of patients with newly diagnosed untreated multiple myeloma
ational Hospital Organization,0 sites150 target enrollmentFebruary 1, 2017
ConditionsMultiple Myeloma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Multiple Myeloma
- Sponsor
- ational Hospital Organization,
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. 19 years or younger 2\. Patients identified as ineligible by the directors and co\-working of each institute.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Targeted Therapy of Advanced Biliary Tract Cancers - A Phase 2 Clinical StudyCTRI/2020/05/025147Armed Forces Medical Research Committee
Completed
Not Applicable
Research on genomic test utilizing next generation sequencer for solid tumors and development of the genome databaseJPRN-UMIN000028388iigata University995
Recruiting
Not Applicable
A comprehensive gene profile investigation of the patients with high risk etiology of colorectal cancercolorectal cancerJPRN-UMIN000023392Chiba university50
Recruiting
Not Applicable
Whole exome sequencing to unravel the genetics of neuralgic amyotrophyNL-OMON41857eurologie250
Completed
Not Applicable
Genome-wide sequencing for the identification of potential genomic denominators between tumorgenesis factors in neuroblastoma and differentiated thyroid carcinoma in childreNL-OMON40506Academisch Medisch Centrum9